the suggested activity of doxorubicin hydrochloride ( adriamycin ) , cyclophosphamide , and 5-fluorouracil as single agents in the treatment of advanced prostate and/or transitional cell carcinoma led us to examine the response to these drugs used in combination .
C0546861
doxorubicin hydrochloride
C0085752
adriamycin